Cayman 12(R)-HETE

12(R)-HETE is an endogenous active metabolite of the ω-6 PUFA and eicosanoid precursor arachidonic acid.^1,2 It is formed from arachidonic acid (Item Nos. 90010 | 90010.1 | 10006607) by 12R-lipoxygenase (12R-LO), as well as cytochrome P450s (CYPs). 12(R)-HETE binds to the TP receptor in washed isolated human platelets (IC₅₀ = 0.734 µM) and inhibits platelet aggregation induced by the TP receptor agonist I-BOP (Item No. 19600; IC₅₀ = 3.6 µM).³ It also selectively binds to leukotriene B₄ (LTB₄) receptor 2 (BLT₂) over BLT₁ at 5 µM in CHO cell membranes expressing the human receptors.⁴ It increases the proliferation of HT-29 colon cancer cells when used at a concentration of 1 µM.⁵ 12(R)-HETE inhibits the bovine corneal Na⁺/K⁺-ATPase in a concentration-dependent manner and decreases intraocular pressure in rabbits when administered topically at doses of 1, 10, or 50 µg/eye.^6,7 Intracerebroventricular administration of 12(R)-HETE (10 µg/animal) decreases LPS-induced pyresis in rats.⁸

WARNING This product is not for human or veterinary use.